Table 2.
Enzyme | Substrate | Coupling Enzyme | OD | Units/mg | mg added | Units added | |
---|---|---|---|---|---|---|---|
1 | GsPyk | PEP/ADP | LDHa | 340 | 55.2 ± 0.08 | 0.012 | 0.66 |
2 | GsPDH | Pyruvate/CoA/NAD+ | none | 340 | 153.4 ± 0.01b | – | 0.038 |
3 | LlNoxE | NADH | none | 340 | 9.0 ± 0.002 | 0.021 | 0.19 |
4 | EfTHL-HMGR | Acetyl-CoA/NADPH | EfHMGS | 340 | 0.06 ± 0.002c | 0.021 | 0.0013 |
5 | EfHMGSd | Acetyl-CoA/Acetoacetyl-CoA | none | 303 | 0.6 ± 0.01 | 0.014 | 0.0084 |
6 | ScHMGR-t | HMG-CoA | none | 340 | 0.5 ± 0.08 | 0.012 | 0.0060 |
7 | ScMVK | Mevalonate/ATP | PK/LDHa | 340 | 47.0 ± 0.9 | 0.003 | 0.14 |
8 | SsPMVK | Mevalonate-P/ATP | PK/LDHa | 340 | 0.8 ± 0.02 | 0.013 | 0.011 |
9 | ScMDC | Mevalonate-PP/ATP | PK/LDHa | 340 | 4.0 ± .07 | 0.012 | 0.048 |
10 | EcIDI | ND | 0.035e | 0.028 | 0.00098 | ||
11 | PaIspS | ND | 0.156f | 0.016 | 0.0025 | ||
12 | G6PDHa | ND | 200-400c | 0.005 | 1.0 |
From Sigma.
Units/mL.
Assayed in forward direction (synthesis) by coupling to MvaS. NADPH consumption monitored at 340 nm.
Mutant A110G (From Ref. 30).
From Ref. 35.
From Ref. 36.